echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The province's increased varieties exit the medical insurance catalog, and pharmaceutical companies welcome the opportunity to enter the market!

    The province's increased varieties exit the medical insurance catalog, and pharmaceutical companies welcome the opportunity to enter the market!

    • Last Update: 2021-07-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network, February 26, February 23, the Shanxi Provincial Medical Insurance Bureau issued a notice requesting the unified implementation of the 2020 version of the National Medical Insurance Catalog from March 1 and the "Drugs temporarily retained in the original Shanxi Provincial Drug Catalog" (108 Species) All adjustments have been made to the province’s medical insurance, work-related injury insurance, and maternity insurance fund payment coverage
    .
    The province's increased varieties will gradually withdraw from the medical insurance catalogue, which will bring certain fluctuations to the domestic pharmaceutical market, and some pharmaceutical companies will usher in new opportunities to enter the market
    .

    Medicare old varieties orientation machine
    to remain in the health insurance directory of drugs how the layout in the provinces, seize market opportunities? How to use this to expand market share and coverage, thereby increasing sales and expanding market visibility? The author recommends starting from the following aspects: 1.
    Collect the information and withdrawal timetable of the withdrawal from the medical insurance catalog of the provincial added varieties
    .
    2.
    The company formulates a systematic analysis report based on the winning bids of the products in each province and the OTC market sales.
    Each province is required to have an analysis report to see if it can find out the specifics of key provinces, key markets, key products, and key replacement products.
    First-line information, based on the information, formulate a series of variety replacement marketing plans for each province
    .
    3.
    Analyze and summarize the province-added varieties in each province, which exit products are similar to the company's products, find out similar drugs and the company's products to analyze, compare, and summarize, and look for new market opportunities for the company's products in each province
    .
    From January 1, 2021, Henan Province will withdraw all the products added by the province and implement the national medical insurance catalogue, with a total of 320 products withdrawn
    .
    Among them, there are 180 western medicine products and 18 hepatitis-related medicines.
    Two of the products have two dosage forms, totaling 20 products, accounting for 11.
    11% of the 180 products; 140 traditional Chinese medicine products, and hepatitis-related medicines There are 8 products, accounting for 5.
    71% of 140 products
    .
    The two totaled 28 products, accounting for 8.
    75% of 320 products
    .
    The withdrawal of this part of the product from the medical insurance catalog is equivalent to withdrawal from the hospitalThe clinical and OTC markets, in addition to the products that have been used clinically in hospitals, have created a larger market space for liver disease products that are listed in the National Medical Insurance Catalogue and have won local bids, providing opportunities for deployment in the province
    .
    Relevant enterprises can organize the division of labor between marketing department, sales department and the heads of various provinces and regions, and try their best to collect corresponding information and personnel, such as who makes which product and which market, which will help enterprises develop the market for exiting products
    .

      The
    author takes the qualified Chinese patent medicine Qinggandan Damp-heat Agent A as an example, and simply makes a market analysis: The first step is to collect the information on the medical insurance withdrawal list of the province’s increased varieties, analyze it with the enterprise’s products, and find out the corresponding And there is an advantage product
    .
    The second step, A product is national medical insurance, won the bid, Chinese patent medicine, exclusive specification product; belongs to the liver and gallbladder damp-heat agent; the main function is to clear damp-heat, nourish the liver and jaundice, and be used for jaundice and acute jaundice caused by damp-heat stagnation and steaming Patients with hepatitis, infectious hepatitis, chronic hepatitis and damp-heat syndrome
    .
    The third step is to conduct a comparative analysis with the province's added varieties to see which products are consistent with or similar to A products, and determine which products A products can replace and which markets they occupy
    .
    The fourth step is to analyze the advantages of product A.
    It is recommended to conduct a detailed analysis of the product from both clinical and sales aspects to achieve the maximum clinical effect and product benefits
    .
    The fifth step is to organize the marketing department and the sales department, especially the provincial managers in charge of the province, to find the generations, distribution companies, and clinical representatives who originally did the province’s increase in variety, so as to replace products and occupy the market as much as possible in the whole process
    .
    For the pharmaceutical market, 2020 is an extraordinary year, and 2021 is still an extraordinary year
    .
    Jicai further deepening and expansion of the country's new health insurance directory execution, province by species to exit the health insurance directory, epidemic prevention and control of strict and normalization, rural medical market more rigorous management, to pharmaceutical production enterprisesPut forward a more difficult subject: how to "seeking new opportunities and new games", increase the market share and coverage of products, and improve sales performance? Pharmaceutical companies can get more enlightenment and ideas from the province’s 2021 withdrawal from the medical insurance catalog
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.